Huakang Biomedical Holdings Company Limited Stock
Equities
8622
KYG4644W1069
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.087 HKD | -1.14% | -13.00% | -18.69% |
Sales 2022 | 25.33M 3.5M 27.35M | Sales 2023 | 24.63M 3.4M 26.59M | Capitalization | 40.7M 5.62M 43.94M |
---|---|---|---|---|---|
Net income 2022 | -3M -414K -3.24M | Net income 2023 | -5M -690K -5.4M | EV / Sales 2022 | 1.43 x |
Net cash position 2022 | 31.43M 4.34M 33.93M | Net cash position 2023 | 27.8M 3.84M 30.02M | EV / Sales 2023 | 0.52 x |
P/E ratio 2022 |
-21.5
x | P/E ratio 2023 |
-7
x | Employees | 96 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.96% |
1 day | -1.14% | ||
1 week | -13.00% | ||
1 month | -11.22% | ||
3 months | -32.56% | ||
6 months | -23.68% | ||
Current year | -18.69% |
Managers | Title | Age | Since |
---|---|---|---|
Chun Guang Zhang
CEO | Chief Executive Officer | 56 | 17-08-02 |
Lai Yin Poon
DFI | Director of Finance/CFO | 52 | 17-08-02 |
Jia Ming He
BRD | Director/Board Member | 38 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lai Yin Poon
DFI | Director of Finance/CFO | 52 | 17-08-02 |
Faat Ting Cheng
BRD | Director/Board Member | 56 | 20-08-31 |
Director/Board Member | 51 | 20-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.087 | -1.14% | 400,000 |
24-05-30 | 0.088 | -2.22% | 384,000 |
24-05-29 | 0.09 | -10.89% | 1,248,000 |
24-05-28 | 0.101 | +4.12% | 160,000 |
24-05-27 | 0.097 | -3.00% | 144,000 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.69% | 5.57M | |
-3.43% | 12.45B | |
-3.17% | 8.22B | |
+6.11% | 5.72B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B |
- Stock Market
- Equities
- 8622 Stock